Global Transdermal Drug Delivery Systems Market Size & Outlook
Global transdermal drug delivery systems market, 2018-2030 (US$M)
Related Markets
No records
No related markets found.
Global transdermal drug delivery systems market highlights
- The global transdermal drug delivery systems market generated a revenue of USD 62,481.8 million in 2023 and is expected to reach USD 136,744.2 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 11.8% by 2030.
- In terms of segment, iontophoresis accounted for a revenue of USD 9,073.8 million in 2023.
- Mechanical arrays is the most lucrative technology segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2023.
- Country-wise, Thailand is expected to register the highest CAGR from 2024 to 2030.
Global data book summary
| Market revenue in 2023 | USD 62,481.8 million |
| Market revenue in 2030 | USD 136,744.2 million |
| Growth rate | 11.8% (CAGR from 2023 to 2030) |
| Largest segment | Iontophoresis |
| Fastest growing segment | Mechanical arrays |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Electroporation, Radio Frequency, Iontophoresis, Microporation, Thermal, Mechanical arrays, Ultrasound |
Other key industry trends
- In terms of revenue, the North America accounted for 61.5% of the global transdermal drug delivery systems market in 2023.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Thailand is the fastest growing regional market and is projected to reach USD 1,368.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Transdermal Drug Delivery Systems Market Scope
Transdermal Drug Delivery Systems Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global transdermal drug delivery systems market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to transdermal drug delivery systems market will help companies and investors design strategic landscapes.
Iontophoresis was the largest segment with a revenue share of 14.52% in 2023. Horizon Databook has segmented the Global transdermal drug delivery systems market based on electroporation, radio frequency, iontophoresis, microporation, thermal, mechanical arrays, ultrasound covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Transdermal Drug Delivery Systems Technology Outlook (Revenue, USD Million, 2018-2030)
- Electroporation
- End use
- Hospital
- Outpatient Facilities
- Home Care
- Research And Manufacturing
- End use
- Radio Frequency
- End Use
- Hospital
- Outpatient Facilities
- Home Care
- Research And Manufacturing
- End Use
- Iontophoresis
- End use
- Hospital
- Outpatient Facilities
- Home Care
- Research And Manufacturing
- End use
- Microporation
- End use
- Hospital
- Outpatient Facilities
- Home Care
- Research And Manufacturing
- End use
- Thermal
- End use
- Hospital
- Outpatient Facilities
- Home Care
- Research And Manufacturing
- End use
- Mechanical arrays
- End use
- Hospital
- Outpatient Facilities
- Home Care
- Research And Manufacturing
- End use
- Ultrasound
- End use
- Hospital
- Outpatient Facilities
- Home Care
- Research And Manufacturing
- End use
- Others
- End use
- Hospital
- Outpatient Facilities
- Home Care
- Research And Manufacturing
- End use
- Electroporation
Reasons to subscribe to Global transdermal drug delivery systems market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global transdermal drug delivery systems market databook
-
Our clientele includes a mix of transdermal drug delivery systems market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global transdermal drug delivery systems market , including forecasts for subscribers. This global databook contains high-level insights into Global transdermal drug delivery systems market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global transdermal drug delivery systems market size, by regions, 2018-2030 (US$M)
Top 10 countries: Transdermal drug delivery systems market size, 2023 (US$M)
Global transdermal drug delivery systems market share, by technology, 2023 & 2030 (%, US$M)
Transdermal drug delivery systems market: Opportunity assessment by country
Global transdermal drug delivery systems market, by region, 2023 (US$M)
| Technology | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 25,319.8 | 28,016.3 | 28,234.6 | 31,185.1 | 34,587.2 | 38,409.6 | 42,693.8 | 47,527.9 | 52,965.5 | 59,056.4 | 65,882.4 | 73,542.6 | 82,327.3 | 11.5% |
| Europe | 9,428.5 | 10,461.2 | 10,571.6 | 11,708.6 | 13,021.9 | 14,501.3 | 16,163.8 | 18,040.9 | 20,162.5 | 22,545.8 | 25,224.3 | 28,238.7 | 31,703.5 | 11.8% |
| Asia Pacific | 4,678.7 | 5,266.3 | 5,397.7 | 6,061.8 | 6,834.4 | 7,713.6 | 8,712.2 | 9,853.9 | 11,155.1 | 12,632.2 | 14,309.7 | 16,217.1 | 18,427.7 | 13.3% |
| Latin America | 779.3 | 872.4 | 889.4 | 993.8 | 1,115.0 | 1,252.7 | 1,408.7 | 1,586.7 | 1,789.1 | 2,018.6 | 2,278.1 | 2,573.2 | 2,914.5 | 12.8% |
| MEA | 383.0 | 427.2 | 434.0 | 483.2 | 540.2 | 604.7 | 677.4 | 760.1 | 853.6 | 959.2 | 1,078.2 | 1,215.7 | 1,371.2 | 12.4% |
| Overall | 40,589.3 | 45,043.4 | 45,527.3 | 50,432.4 | 56,098.7 | 62,481.8 | 69,655.9 | 77,769.5 | 86,925.9 | 97,212.1 | 108,772.7 | 121,787.2 | 136,744.2 | 11.8% |
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
